ETF Managers Group, LLC Biomarin Pharmaceutical Inc Transaction History

ETF Managers Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $1.35 Million - $1.64 Million	18,833 New	18,833 $1.58 Million
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $60,884 - $79,323	-801 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $7,767 - $9,263	100 Added 14.27%	801 $62,000
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $8,076 - $9,513	100 Added 16.64%	701 $64,000
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $48,440 - $57,064	601	601 $56,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.